Evidence map›Paper›PMID 30823394›Full record

ArticleMolecules (Basel, Switzerland)2019

Cytotoxic Properties of Damiana (

Johanna Willer, Karin Jöhrer, Richard Greil, Christian Zidorn, Serhat Sezai Çiçek

Abstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Bioactivity of the GenusPharmaceuticals (Basel, Switzerland) · 2023
    Review
  5. Flavones, Flavonols, Lignans, and Caffeic Acid Derivatives fromInternational journal of molecular sciences · 2022
    Article
  6. Article
  7. Antiphotoaging Effects of Damiana (Plants (Basel, Switzerland) · 2022
    Article
  8. Article
  9. Development of a Hepatoprotective Herbal Drug fromEvidence-based complementary and alternative medicine : eCAM · 2022
    Article
  10. Review
  11. Article
  12. Article
  13. Antitumoral Properties of Natural Products.Molecules (Basel, Switzerland) · 2020
    Article
  14. Interpol review of controlled substances 2016-2019.Forensic science international. Synergy · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Johanna WillerDepartment of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany. jwiller@pharmazie.uni-kiel.de.
Karin JöhrerTyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria. karin.joehrer@tkfi.at.ORCID 0000-0002-6400-6175
Richard GreilTyrolean Cancer Research Institute, Innrain 66, 6020 Innsbruck, Austria. r.greil@salk.at.ORCID 0000-0002-4462-3694
Christian ZidornDepartment of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany. czidorn@pharmazie.uni-kiel.de.ORCID 0000-0001-8956-9874
Serhat Sezai ÇiçekDepartment of Pharmaceutical Biology, Kiel University, Gutenbergstraße 76, 24118 Kiel, Germany. scicek@pharmazie.uni-kiel.de.ORCID 0000-0002-3038-8523

Funding

Land Schleswig-Holstein Open Access Publikationsfonds
6 · The paper itself

Abstract

In our continuing search for new cytotoxic agents, we assayed extracts, fractions, and pure compounds from damiana (

Indexed as

Antineoplastic Agents, PhytogenicCytotoxinsPlant ExtractsCell Line, TumorChromatography, High Pressure LiquidHumansMultiple MyelomaSpectrometry, Mass, Electrospray IonizationTurneraAntineoplastic Agents, PhytogenicCytotoxinsPlant Extractsflavonoidsmultiple myelomanaringeninquality controltraditional preparation

Identifiers

PMID30823394
PMCPMC6429218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.